Fenofibrate Zydus

Fenofibrate (Nanonised) by Zydus France is a medication used to manage cholesterol and triglyceride levels. This oral medication is designed to support cardiovascular health by improving lipid profiles.

Fenofibrate (Nanonised) is primarily used to lower elevated triglyceride levels and increase HDL (good cholesterol) levels in the blood. It is often prescribed for individuals with high cholesterol or mixed dyslipidemia, conditions where lipid levels are not within the desired range. This medication works by reducing the production of triglycerides in the liver and enhancing the breakdown of fats.

Common effects of Fenofibrate (Nanonised) may include gastrointestinal discomfort, such as nausea or stomach pain. Some users might experience muscle pain or weakness. These effects are generally mild and temporary, but if they persist or worsen, it is important to consult a healthcare provider.

Fenofibrate (Nanonised) should be used with caution in individuals with liver or kidney disease. Regular monitoring of liver function and kidney function tests may be recommended. It is important to follow the prescribed dosage and not to exceed the recommended amount without medical advice.

Fenofibrate (Nanonised) may interact with certain medications, including blood thinners, other cholesterol-lowering drugs, and some antibiotics. Alcohol consumption should be limited as it can increase the risk of side effects. Always inform your healthcare provider about all medications and supplements you are taking.